Ginkgo Bioworks Holdings (DNA) Prepaid Assets (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Prepaid Assets of $16.2 million for Q1 2026, down 34.98% on a QoQ basis from $25.0 million in Q4 2025, and down 20.6% year-over-year from $20.4 million in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Prepaid Assets (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Prepaid Assets history runs 7 years deep, the most recent figure standing at $16.2 million for Q1 2026.
- Quarterly Prepaid Assets fell 20.6% year-over-year to $16.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.2 million (down 20.6% YoY) and the FY2025 annual result came in at $25.0 million, up 33.29% from the prior year.
- Prepaid Assets was $16.2 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $25.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $48.4 million in Q2 2023 and bottomed at $487000.0 in Q4 2022.
- A 5-year average of $28.5 million and a median of $29.4 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 8067.76% — and 2024, when it slumped 52.92%.
- Ginkgo Bioworks Holdings' Prepaid Assets stood at $487000.0 in 2022, then jumped by 8067.76% to $39.8 million in 2023, then slumped by 52.92% to $18.7 million in 2024, then jumped by 33.29% to $25.0 million in 2025, then tumbled by 34.98% to $16.2 million in 2026.
- Business Quant data shows DNA's Prepaid Assets at $16.2 million in Q1 2026, $25.0 million in Q4 2025, and $21.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.23 Mn |
| Dec 31, 2025 | 24.96 Mn |
| Sep 30, 2025 | 21.86 Mn |
| Jun 30, 2025 | 26.21 Mn |
| Mar 31, 2025 | 20.44 Mn |
| Dec 31, 2024 | 18.73 Mn |
| Sep 30, 2024 | 22.32 Mn |
| Jun 30, 2024 | 34.10 Mn |
| Mar 31, 2024 | 38.02 Mn |
| Dec 31, 2023 | 39.78 Mn |
| Sep 30, 2023 | 29.39 Mn |
| Jun 30, 2023 | 48.36 Mn |
| Mar 31, 2023 | 33.87 Mn |
| Dec 31, 2022 | 487,000.00 |
| Sep 30, 2022 | 37.78 Mn |
| Jun 30, 2022 | 38.72 Mn |
| Mar 31, 2022 | 33.09 Mn |
| Dec 31, 2021 | 698,000.00 |
| Sep 30, 2021 | 17.31 Mn |
| Jun 30, 2021 | 929,250.00 |